Live Breaking News & Updates on Cereval therapeutics

Stay informed with the latest breaking news from Cereval therapeutics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Cereval therapeutics and stay connected to the pulse of your community

Bristol Myers Squibb to buy Karuna Therapeutics for $14bn

Biopharmaceuticals giant Bristol Myers Squibb has announced it is spending $14bn to purchase Karuna Therapeutics, which develops treatments for people living with psychiatric and neurological conditions.

Christopher-boerner , Dow-jones , Mizuho-securities , Cereval-therapeutics , Bristol , Myers , Squibb , Karuna , Therapeutics , 4bn , Category-all , Category-company-news


georgetown.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from georgetown.edu Daily Mail and Mail on Sunday newspapers.

New-york , United-states , Caen , Basse-normandie , France , Massachusetts , Washington , Boston , Georgetown-university , District-of-columbia , American , Wolters-kluwer-uptodate